Trade pact with EU won’t impact pharma industry: India

India Friday said the free trade agreement with the European Union will not bar its pharma companies from manufacturing and exporting generic drugs. “Nothing in the agreement would limit TRIPS (Trade Related Intellectual Property Rights) flexibilities concerning access to medicines,” according to a report on the progress of Broad Based Trade and Investment Agreement (BTIA) from the commerce ministry said